Celularity Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Celularity Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $80 per $100 of sales comes from others' credit, against $36 tied up three years earlier. Less money tied up than 97% of Healthcare companies in United States.
- Growth Efficiency Ratio: Sales grew 48% in 3 years, but profit fell: $1,235 less profit per $100 of extra sales. Lower than 96% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, is 1.0 times its market value (net debt). Lower than 95% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
−$80Money owed to suppliers is larger than money owed by customers plus stock: $80 per $100 of sales comes from others' credit, against $36 tied up three years earlier.
Less money tied up than 97% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Less steady than 51% of Healthcare companies in United States.
Growth Efficiency Ratio
−$1,235Sales grew 48% in 3 years, but profit fell: $1,235 less profit per $100 of extra sales.
Lower than 96% of Healthcare companies in United States.
Asset Productivity Ratio
+48% / -73%In 3 years sales changed by +48% while total assets changed by -73%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-0.9×Operating cash was negative last year, while some debt falls due within a year.
Higher than 66% of Healthcare companies in United States.
Cash Cushion Ratio
1.0× debtDebt, after subtracting cash, is 1.0 times its market value (net debt).
Lower than 95% of Healthcare companies in United States.
Tangible Assets Ratio
86%Of every $100 the company owns, $86 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 57% of Healthcare companies in United States.
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Celularity Inc. made a loss over the last year. Celularity Inc. owes $1.35 for every $1 it owns. Celularity Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossCelularity Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-0.83Celularity Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$32 MThe total market value of all of Celularity Inc.'s shares at today's price (share price × number of shares), smaller than 79% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
NegativeCelularity Inc.'s net worth is negative ($38 M below zero, balance sheet 31 Dec 2025): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.35×Celularity Inc. owes $1.35 for every $1 it owns, so it owes more than it owns, higher than 92% of Healthcare companies in United States.
Dividend yield
NoneCelularity Inc. does not currently pay a dividend.
Revenue growth
-51%Revenue fell 51% in the year to Dec 2025, and grew 14% a year on average over 3 years.
Profit growth
LossCelularity Inc. made a loss in each of the last two years.
Profit margin
-345.4%Celularity Inc. lost $345 for every $100 of revenue.
Interest cover
Not coveredCelularity Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtCelularity Inc. had $35 M more debt than cash (net debt) at Dec 2025.
Questions
How much does Celularity Inc. owe compared with what it owns?
Celularity Inc. owes $1.35 for every $1 it owns, so it owes more than it owns, higher than 92% of Healthcare companies in United States.
Does Celularity Inc. pay a dividend?
No. Celularity Inc. does not currently pay a dividend.
Is Celularity Inc.'s revenue growing?
Revenue fell 51% in the year to Dec 2025, and grew 14% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.